Chloroquine Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Chloroquine is an aminoquinolone derivative originally developed in the 1940s for the treatment of malaria. It was chosen to treat malaria until the development of newer antimalarials such as artemisinin, pyrimethamine, and mefloquine. This drug is preferred for the treatment of different types of parasites and is administered through the oral route. These drugs are derived from quinoline molecules and have similar clinical indications and side effects.

MARKET DYNAMICS

Growing prevention and treatment of malaria, rheumatoid arthritis, and other autoimmune diseases along with the increasing prevalence of COVID-19 cases are the major factors for market growth. Moreover, due to COVID-19 pandemic, export and import of chloroquine across regions has been increased which is additionally impelling the market growth.

MARKET SCOPE

The "Chloroquine Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Chloroquine market with detailed market segmentation by product and application. The Chloroquine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Chloroquine market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The chloroquine market is segmented on the basis of product and application. Based on product, the market is segmented as injectables, capsules, and tablets. Based on application, the market is segmented as malaria, rheumatoid arthritis, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Chloroquine market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Chloroquine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Chloroquine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Chloroquine market in these regions.

MARKET PLAYERS

The report covers key developments in the Chloroquine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Chloroquine market are anticipated to have lucrative growth opportunities in the future with the rising demand for Chloroquine in the global market. Below mentioned is the list of few companies engaged in the Chloroquine market.

The report also includes the profiles of key players in Chloroquine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and product and application s offered, financial information of last 3 years, key development in past five years.

•   ABCAM PLC
  
•   ADVANZ PHARMA CORP.
  
•   BAYER AG
  
•   CADILA HEALTHCARE LTD.
  
•   IPCA LABORATORIES LTD.
  
•   MYLAN NV
  
•   NOVARTIS AG
  
•   SANOFI
  
•   SUN PHARMACEUTICAL INDUSTRIES LTD.
  
•   TEVA PHARMACEUTICAL INDUSTRIES LTD.
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Chloroquine Report Scope